In l-DOPA naïve rats, SKF 81297 induced moderate dyskinesia within 30 min of injection, whereas activation of PKA and ERK1/2 occurred as early as 5 min post-injection, and peaked 10–15 min prior to the first AIMs (Fig. 6a,c). The gene discussed is MAPK3; the disease is drug-induced dyskinesia.